- Home
- WTBA vs ZURA Comparison
WTBA vs ZURA Comparison
Compare WTBA & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WTBA | ZURA |
|---|---|---|
| Founded | 1893 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 342.0M | 252.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | WTBA | ZURA |
|---|---|---|
| Price | $23.70 | $4.07 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | ★ $23.50 | $11.38 |
| AVG Volume (30 Days) | 33.3K | ★ 359.5K |
| Earning Date | 01-22-2026 | 11-13-2025 |
| Dividend Yield | ★ 4.26% | N/A |
| EPS Growth | ★ 49.53 | N/A |
| EPS | ★ 1.90 | N/A |
| Revenue | ★ $91,783,000.00 | N/A |
| Revenue This Year | $25.05 | N/A |
| Revenue Next Year | $10.87 | N/A |
| P/E Ratio | $12.36 | ★ N/A |
| Revenue Growth | ★ 19.66 | N/A |
| 52 Week Low | $17.31 | $0.97 |
| 52 Week High | $23.84 | $4.68 |
Technical Indicators
Market Signals| Indicator | WTBA | ZURA |
|---|---|---|
| Relative Strength Index (RSI) | 71.08 | 58.82 |
| Support Level | $22.12 | $3.58 |
| Resistance Level | $22.75 | $3.94 |
| Average True Range (ATR) | 0.49 | 0.25 |
| MACD | 0.11 | 0.02 |
| Stochastic Oscillator | 91.79 | 82.96 |
Price Performance
Historical ComparisonAbout WTBA West Bancorporation
West Bancorp Inc is a United States-based company that offers a full range of deposit services, including checking, savings and money market accounts and time certificates of deposit. West Bank also offers online banking, mobile banking, and treasury management services, which help to meet the banking needs of its customers. Treasury management services offered to business customers include cash management, client-generated automated clearing house transactions, remote deposit, and fraud protection services. Also offered are merchant credit card processing and corporate credit cards. The bank operates only in the United States of America region.
About ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.